Development of a novel chemokine-mediated in vivo T cell recruitment assay

Journal of Immunological Methods

Volumn 331, Issue 1-2, 2008, Pages 127-139

  Campanella, Gabriele S V ^a   Medoff, Benjamin D ^a   Manice, Lindsay A ^a   Colvin, Richard A ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cell trafficking; Chemokines; Chemotaxis

Indexed keywords

ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADOPTIVE TRANSFER; AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; LYMPHOCYTE HOMING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; INFLAMMATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE;

MUS;

EID: 39149093950     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.12.002     Document Type: Article

References (34)

1. Balashov K.E., Rottman J.B., Weiner H.L., and Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 6873
2. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67 (1991) 1033
3. Campanella G.S., Grimm J., Manice L.A., Colvin R.A., Medoff B.D., Wojtkiewicz G.R., Weissleder R., and Luster A.D. Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J. Immunol. 177 (2006) 6991
4. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 (2006) 610
5. Colvin R.A., Campanella G.S., Sun J., and Luster A.D. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J. Biol. Chem. 279 (2004) 30219
6. Gladue R.P., Cole S.H., Roach M.L., Tylaska L.A., Nelson R.T., Shepard R.M., McNeish J.D., Ogborne K.T., and Neote K.S. The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice. J. Immunol. 176 (2006) 3141
7. + T cell effectors that cause myocarditis. J. Clin. Invest. 111 (2003) 671
8. Hancock W.W., Lu B., Gao W., Csizmadia V., Faia K., King J.A., Smiley S.T., Ling M., Gerard N.P., and Gerard C. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192 (2000) 1515
9. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., and Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36 (1997) 13570
10. Khan I.A., MacLean J.A., Lee F.S., Casciotti L., DeHaan E., Schwartzman J.D., and Luster A.D. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12 (2000) 483
11. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436
12. Luster A.D., Greenberg S.M., and Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182 (1995) 219
13. Luster A.D., Unkeless J.C., and Ravetch J.V. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315 (1985) 672
14. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., and Luster A.D. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 104 (1999) 1041
15. Medoff B.D., Seung E., Wain J.C., Means T.K., Campanella G.S., Islam S.A., Thomas S.Y., Ginns L.C., Grabie N., Lichtman A.H., Tager A.M., and Luster A.D. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med. 202 (2005) 97-110
16. Melter M., Exeni A., Reinders M.E., Fang J.C., McMahon G., Ganz P., Hancock W.W., and Briscoe D.M. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104 (2001) 2558
17. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., and Rot A. Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells. Cell 91 (1997) 385
18. Narumi S., Tominaga Y., Tamaru M., Shimai S., Okumura H., Nishioji K., Itoh Y., and Okanoue T. Expression of IFN-inducible protein-10 in chronic hepatitis. J. Immunol. 158 (1997) 5536
19. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., and Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1885
20. Saetta M., Mariani M., Panina-Bordignon P., Turato G., Buonsanti C., Baraldo S., Bellettato C.M., Papi A., Corbetta L., Zuin R., Sinigaglia F., and Fabbri L.M. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165 (2002) 1404
21. Sauty A., Colvin R.A., Wagner L., Rochat S., Spertini F., and Luster A.D. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J. Immunol. 167 (2001) 7084
22. Sauty A., Dziejman M., Taha R.A., Iarossi A.S., Neote K., Garcia-Zepeda E.A., Hamid Q., and Luster A.D. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162 (1999) 3549
23. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., and Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103 (1999) 807
24. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301
25. Spurrell J.C., Wiehler S., Zaheer R.S., Sanders S.P., and Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L85
26. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., and Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361 (1993) 79
27. Taub D.D., Lloyd A.R., Conlon K., Wang J.M., Ortaldo J.R., Harada A., Matsushima K., Kelvin D.J., and Oppenheim J.J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177 (1993) 1809
28. Taub D.D., Sayers T.J., Carter C.R., and Ortaldo J.R. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155 (1995) 3877
29. Wang L., Fuster M., Sriramarao P., and Esko J.D. Endothelial heparan sulfate deficiency impairs L-selectin-and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6 (2005) 902
30. Weng Y., Siciliano S.J., Waldburger K.E., Sirotina-Meisher A., Staruch M.J., Daugherty B.L., Gould S.L., Springer M.S., and DeMartino J.A. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 273 (1998) 18288
31. Xie H., Lim Y.C., Luscinskas F.W., and Lichtman A.H. Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells. J. Exp. Med. 189 (1999) 1765
32. Zhao D.X., Hu Y., Miller G.G., Luster A.D., Mitchell R.N., and Libby P. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J. Immunol. 169 (2002) 1556
33. Zicha D., Dunn G.A., and Brown A.F. A new direct-viewing chemotaxis chamber. J. Cell Sci. 99 Pt 4 (1991) 769
34. Zigmond S.H. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J. Cell Biol. 75 (1977) 606